亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

岳陽市嘉誠生物科技有限公司銷售部  

高效氯氟氰菊酯,匹可硫酸鈉,溴蟲睛,3,4,5一三甲氧基肉桂酸,2,4一二羥基苯甲酸,三乙脂,烯丙基硫脲

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:熊先生
  • 電話:0730-8705981
  • 郵件:gcns08@ycgmp.com
  • 傳真:0730-8705981
  • QQ:2355779402
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 供應廠家千層塔提取物
供應廠家千層塔提取物
單價 面議對比
詢價 暫無
發貨 湖南岳陽市付款后3天內
品牌 南箭
過期 長期有效
更新 2019-06-27 09:08
 
詳細信息
 中文名稱: 千層塔提取物 
中文同義詞: 千層塔提取物;千層塔提取物 HUPERZIA SERRATC P.E. 
英文名稱: Huperzia Serrate P.E 
千層塔提取物為千層塔Huperzta serrata Trev.干燥全草的提取物,主要活性成分為生物堿類,具有散瘀止血,清熱利濕,解毒,消腫,止痛的功能。主治跌打損傷、勞傷吐血、水腫臌脹、濕熱白帶、尿血、便血、癰疽瘡毒、潰瘍久不收口、燙火傷以及膽道蛔蟲引起之劇烈腹痛等證。
千層塔的主要制劑有:石杉堿甲片(雙益平) (WS-446 (X-386)-95),每片含石杉堿甲0.05mg,對老年良性癡呆癥及阿爾海默氏癥有良好的療效; 置于陰涼干燥、避光,避高溫處
©2025 岳陽市嘉誠生物科技有限公司銷售部 版權所有   技術支持:化工網   訪問量:12195  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |